The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Egorov A.Iu.

Institut évoliutsionnoĭ fiziologii i biokhimii im. I.M. Sechenova RAN

Zobin M.L.

Meditsinskiĭ tsentr lecheniia narkoticheskoĭ i alkogol'noĭ zavisimosti, Moskva

The peculiarities of remissions in opioid dependence

Authors:

Egorov A.Iu., Zobin M.L.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(5‑2): 55‑66

Read: 14233 times

Download PDF (RU)
Contact the author
Table of contents

THE PECULIARITIES OF REMISSIONS IN OPIOID DEPENDENCE
THE PECULIARITIES OF REMISSIONS IN OPIOID DEPENDENCE

To cite this article:

Egorov AIu, Zobin ML. The peculiarities of remissions in opioid dependence. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(5‑2):55‑66. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Factors influencing the achievement of remi­ssion in patients with alco­hol depe­ndence and concomitant psychological diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):21-30
Quantitative electroencephalogram in fema­les at different stages of alco­hol remi­ssion. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):122-126
Abstract:

Keywords:

opioid dependence
remission
follow up studies

Authors:

Egorov A.Iu.

Institut évoliutsionnoĭ fiziologii i biokhimii im. I.M. Sechenova RAN

Zobin M.L.

Meditsinskiĭ tsentr lecheniia narkoticheskoĭ i alkogol'noĭ zavisimosti, Moskva

Close metadata

References:

  1. Al'tshuler V.B. Patologicheskoe vlechenie k alkogolyu. M 1994;216.
  2. Babayan E.A., Gonopol'skii M.Kh. Narkologiya. M: Meditsina 1987;336.
  3. Valentik Yu.V. (red) Rukovodstvo po reabilitatsii nesovershennoletnikh, zloupotreblyayushchikh narkoticheskimi veshchestvami. M: Genzher 2003;400.
  4. Vinnikova M.A. Remissii pri geroinovoi narkomanii (klinika, etapy techeniya, profilaktika retsidivov): Avtoref. dis. ... d-ra med. nauk. M 2004;33.
  5. Gofman A.G. Illyuzii zamestitel'noi terapii narkomanii. Nezavisimyi psikhiat zhurn 2006;1:69-71.
  6. Dobrovol'skii A.P. Kliniko-biologicheskaya otsenka effektivnosti lecheniya abstinentnogo i postabstinentnogo sostoyaniya u lits, stradayushchikh geroinovoi narkomaniei: Avtoref. dis. ... kand. med. nauk. M 2005;24.
  7. Eryshev O.F., Rybakova E.G., Shabanov P.D. Alkogol'naya zavisimost': formirovanie, techenie, protivoretsidivnaya terapiya. St-Peterburg: Elbi SPb 2002;192.
  8. Zobin M.L. Addiktivnyi profil' - novyi instrument dlya otsenki rezul'tatov lecheniya (adaptirovannaya versiya). Psikhicheskoe zdorov'e 2007;12:39-43.
  9. Ivanets N.N. Lektsii po narkologii. 2-e izd., pererab. M: Nolidzh 2000;435.
  10. Ivanets N.N., Vinnikova M.A. Geroinovaya zavisimost' (klinika i lechenie postabstinentnogo sostoyaniya). M: Medpraktika-M 2001;128.
  11. Ivanets N.N., Vinnikova M.A. Sovremennaya kontseptsiya terapii narkologicheskikh zabolevanii. Rukovodstvo po narkologii. Pod red. N.N. Ivantsa. M: Medpraktika 2002;2:6-24.
  12. Kaplan G.I., Sedok B.Dzh. Klinicheskaya psikhiatriya. V 2 t. M: Meditsina 1994; 1:672.
  13. Kesel'man L.E., Matskevich M.G. Sotsial'noe prostranstvo narkotizma. 2-e izd., pererab. i dop. St-Peterburg: Meditsinskaya pressa 2001;272.
  14. Kitkina T.A. Tipologiya remissii u bol'nykh opiinoi narkomaniei. V sb.: Materialy mezhdunarodnoi konferentsii. Ch. II. Grodno 1993;328-329.
  15. Krasnov V.N., Ivanets N.N., Dmitrieva T.B. i dr. Net metadonovym programmam v Rossii. Vopr narkol 2005;2:4-8.
  16. Krupitskii E.M., Grinenko A.Ya. Stabilizatsiya remissii pri alkogolizme. St-Peterburg: Gippokrat 1996;96.
  17. Krupitskii E.M. Primenenie farmakologicheskikh sredstv dlya stabilizatsii remissii i profilaktiki retsidivov pri alkogolizme: zarubezhnye issledovaniya. Vopr narkol 2003;3:51-61.
  18. Krupitskii E.M., Zvartau E.E., Tsoi M.V. i dr. Dvoinoe slepoe randomizirovannoe platsebo-kontroliruemoe issledovanie effektivnosti naltreksona dlya stabilizatsii remissii u bol'nykh geroinovoi narkomaniei. Vopr narkol 2005;3:24-34.
  19. Mendelevich V.D. Problema narkomanii v Rossii: stolknovenie interesov spetsialistov, patsientov, obshchestva i vlasti (kliniko-sotsiologicheskoe issledovanie). Kazan': Shkola 2004;240.
  20. Nadezhdin A.V. K voprosu o «zamestitel'noi terapii» u bol'nykh geroinovoi narkomaniei. Vopr narkol 2001;5:66-71.
  21. Nadezhdin A.V. Perspektivy vnedreniya «zamestitel'noi terapii» u bol'nykh opioidnoi narkomaniei v Rossii. Narkologiya 2002;2:42-44.
  22. Nadezhdin A.V., Voronkov A.A., Tetenova E.Yu., Avdeev S.N. Antidepressant fevarin v kompleksnoi terapii opioidnoi zavisimosti. Vopr narkol 2002;3:26-33.
  23. Portnov A.A., Pyatnitskaya I.N. Klinika alkogolizma. L 1971;387.
  24. Pyatnitskaya I.N. Narkomanii. Rukovodstvo dlya vrachei. M: Meditsina 1994; 544.
  25. Pyatnitskaya I.N., Zobin M.L. Korotkaya ambulatornaya programma lecheniya opiinoi narkomanii v rannem postabstinentnom periode. Narkologiya 2004;6:52-56.
  26. Rokhlina M.L., Voronin K.E. Remissii i prichiny retsidivov u bol'nykh mono- i polinarkomaniyami. Profilaktika retsidivov pri alkogolizme i narkomaniyakh. Sbornik nauchnykh trudov. St-Peterburg 1991;46-50.
  27. Rokhlina M.L., Kozlov A.A. Narkomanii. Meditsinskie i sotsial'nye posledstviya. Lechenie. M: Anakharsis 2001;208.
  28. Sivolap Yu.P. Otsenka roli raznykh klassov lekarstvennykh sredstv v terapii opioidnoi zavisimosti. Zhurn nevrol i psikhiat 2004;104:1:31-36.
  29. Sivolap Yu.P., Savchenkov V.A. Zloupotreblenie opioidami i opioidnaya zavisimost'. M: Meditsina 2005;301.
  30. Sovmestnaya pozitsiya VOZ/UOONNP/YuNEIDS. Zamestitel'naya podderzhivayushchaya terapiya v vedenii patsientov s opioidnoi zavisimost'yu i v profilaktike VICh-infektsii i SPID. VOZ, Zheneva, 2004;36.
  31. Tsetlin M.G., Pelipas V.E. Reabilitatsiya narkologicheskikh bol'nykh: kontseptsiya i prakticheskaya programma. M 2000;36.
  32. Chirko V.V., Demina M.V. Ocherki klinicheskoi narkologii (narkomanii i toksikomanii: klinika, techenie, terapiya). M: Medpraktika-M 2002;240.
  33. Shabanov P.D. Rukovodstvo po narkologii. 2-e izd. St-Peterburg: Lan' 1999.
  34. Shabanov P.D., Shtakel'berg O.Yu. Narkomanii: patopsikhologiya, klinika, reabilitatsiya. Pod red. A.Ya. Grinenko. Seriya «Mir meditsiny» St-Peterburg: Lan' 2000;368.
  35. Shaidukova L.K. Osobennosti «remissionnykh» psikhicheskikh rasstroistv u bol'nykh alkogolizmom. Narkologiya 2006;5:64-68.
  36. Entin G.M. Lechenie alkogolizma. M: Meditsina 1990;416.
  37. Adi Y., Juarez-Garcia A., Wang D. et al. Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation. Health Technol Ass 2007;11:6:III-IV:1-85.
  38. Amato L., Minozzi S., Davoli M. et al. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev 2004;4:CD005031.
  39. Andersson B., Nilsson K., Tunving K. Drug careers in perspective. Acta Psychiatr Scand 1983;67:4:249-257.
  40. Bale R.N., Cabrera S., Brown J. Follow-up evaluation of drug abuse treatment. Am J Drug Alcohol Abuse 1977;4:2:233-249.
  41. Bird S.M., Hutchinson S.J. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-1999. Addiction 2003;98:185-190.
  42. Bradley B.P., Phillips G., Green L., Gossop M. Circumstances surrounding the initial lapse to opiate use following detoxification. Br J Psychiat 1989;154:354-359.
  43. Bradley B.P., Gossop M., Brewin C.R. et al. Attribution and relapse in opiate addicts. J Consult Clin Psychol 1992;60:3:470-472.
  44. Brewer D.D., Catalano R.F., Haggerty K. et al. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction 1998;93:1:73-92.
  45. Broome K.M., Simpson D.D., Joe G.W. The role of social support following short-term inpatient treatment. Am J Addict 2002;11:57-65.
  46. Brunswick A.F., Messeri P.A. Pathways to heroin abstinence: a longitudinal study of urban black youth. Adv Alcohol Subst Abuse 1986;5:3:111-135.
  47. Burman S. The challenge of sobriety: natural recovery without treatment and self-help groups. J Subst Abuse 1997;9:41-61.
  48. Capelhorn J. Deaths in the first two weeks of methadone treatment in NSW in 1994: identifying cases of iatrogenic methadone toxicity. Drug Alcohol Rev 1998;17:9-17.
  49. Cloud W., Granfield R. Natural recovery from substance dependency: Lessions for treatment providers. J Social Work Pract Addict 2001;1:1:83-104.
  50. Cornish J.W., Metzger D., Woody G.E. et al. Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 1997;14:529-534.
  51. Cunningham J.A. Remissions from drug dependence: is treatment a prerequisite? Drug Alcohol Depend 2000;59:3:211-213.
  52. Darke S., Hall W., Wodak A. et al. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1992;87:5:733-742.
  53. Darke S., Ross J., Teesson M. et al. Factors associated with 12 month continuous heroin abstinence: findings from the Astralian Treatment Outcome Study (ATOS). J Subst Abuse Treat 2005;28:3:255-263.
  54. De Jong C.A., Roozen H.G., van Rossum L.G. et al. High abstinence rates in heroin addicts by a new comprehensive treatment approach. Am J Addict 2007;16:2:124-130.
  55. Dekel R., Benbenishty R., Amram Y. Therapeutic communities for drug addicts: prediction of high-term outcome. Addict Behav 2004;29:9:1837-1883.
  56. De Leon G., Schwartz S. Therapeutic communities: what are the retention rates? Am J Drug Alcohol Abuse 1984;10:2:267-284.
  57. Dijkstra B.A., De Jong C.A., Bluschke S.M. et al. Does naltrexone affect craving in abstinent opioid-dependent patients? Addict Biol 2007;12:2:176-182.
  58. Downey L., Rosengren D.B., Jackson T.R., Donovan D.M. Primary heroinusers+drug-free treatment. An equation for success? Addictive Behav 2003;28:2:339-346.
  59. Drummond D.C. Theories of drug craving, ancient and modern. Addiction 2001;96:1:33-46.
  60. Edwards J.G., Goldie A. A ten-year follow-up study of Southampton opiate addicts. Br J Psychiat 1987;151:679-683.
  61. ffective medical treatment of opiate addiction. National Consensus Development Panel of Effective Medical Treatment of Opiate Addiction. JAMA 1998;280:22:1936-1943.
  62. Farren C., O`Malley S., Rounsaville B. Naltrexone and opiate abuse. In: New treatment for opiate dependence. Eds. S. Stine, T. Kosten. New York: The Gilford Press 1997;104-123.
  63. Fleischhacker W.W., Kryspin-Exner K. The psychopathology of alcoholism. Drug Alcohol Depend 1986;17:1:73-79.
  64. Flynn P.M., Joe G.W., Broome K.M. et al. Recovery from opioid addiction in DATOS. J Subst Abuse Treat 2003;25:3:177-186.
  65. Frykholm B. Termination of the drug career. An interview study of 58 ex-addicts. Acta Psyhiatr Scand 1979;59:4:370-380.
  66. Ginzburg H.M. Naltrexone: Its clinical utility. Advanc Alcohol Substance Abuse 1986;5:1-2:83-101.
  67. Goelb J.L., Coste J., Bigot T., Ferrand I. Prospective study of favorable factors in follow-up of drug addicted patients: apropos of 257 patients of the Cassini Center in Paris. Encephale 2000;26:6:11-20.
  68. Goldstein P.J., Abbott W., Paige W. et al. Tracking procedures in follow-up studies of drug abusers. Am J Drug Alcohol Abuse 1977;4:21-30.
  69. Goldstin A., Herris J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend 1995;40:2:139-150.
  70. Gossop M., Green L., Phillips G., Bradley B. Lapse, relapse and survival among opiate addicts after treatment. A prospective study. Br J Psychiat 1989;154:348-353.
  71. Gossop M., Green L., Phillips G., Bradley B. Factors predicting outcome among opiate addicts after treatment. Br J Clin Psychol 1990;29:2:209-216.
  72. Gossop M., Marsden J., Stewart D., Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from National Treatment Outcome Research Study. Drug Alcohol Depend 2001;62:3:255-264.
  73. Gossop M., Stewart D., Browne N., Marsden J. Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction 2002;97:10:1259-1267.
  74. Gossop M., Stewart D., Marsden J. et al. Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment. Addict Behav 2004;29:6:1085-1094.
  75. Gossop M., Trakada K., Stewart D., Witton J. Reductions in criminal convictions after addiction treatment: 5-year follow-up. Drug Alcohol Depend 2005;79:3:295-302.
  76. Gruber K., Chutuape M.A., Stitzer M.L. Reinforcement-based intensive outpatient treatment for inner city opiate abusers: a short-term evaluation. Drug Alcohol Depend 2000;57:3:211-223.
  77. Guardo Serecigni J., Masip Vidal J., Viladrich Segues M.C. Follow up study of heroin-addicted persons admitted for treatment in Barcelona. Bull Narcol 1988;40:1:71-74.
  78. Haastrup S., Jepsen P.W. Eleven year follow-up of 300 young opioid addicts. Acta Psychiat Scand 1988;77:1:22-26.
  79. Haro G., Mateu C., Martinez-Raga J. et al. The role of personality disorder on drug dependence treatment outcomes following inpatient detoxification. Eur Psychiat 2004;19:4:187-192.
  80. Harrington P., Cox T.J. A twenty-year follow-up of narcotic addicts in Tucson, Arizona. Am J Drug Alcohol Abuse 1979;6:1:25-37.
  81. Hser Y.I., Anglin M.D., Fletcher B. Comparative treatment effectiveness. Effects of program modality and client drug dependence history on drug use reduction. J Subst Abuse Treat 1998;15:6:513-523.
  82. Hser Y.I., Hoffman V., Grella C.E., Anglin M.D. A 33-year follow-up of narcotics addicts. Arch Gen Psychiat 2001;58:5:503-508.
  83. Hubbard R.L., Craddock S.G., Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat 2003;25:3:125-134.
  84. Hyman S.M., Fox H., Hong K.I. et al. Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment. Exp Clin Psychopharmacol 2007;15:2:134-143.
  85. Jovaiša T., Laurinėnas G., Vosylius S. et al. Effects of ketamine on precipitated opiate withdrawal. Medicina (Kaunas) 2006;42:8:625-634.
  86. Kirshmayer U., Davoli M., Verster A. et al. A systematic review of the efficacy of naltrexone maintenance treatment in opioid dependence. Addiction 2002;97:1241-1249.
  87. Klingemann H.K. Coping and maintenance strategies of spontaneous remitters from problem use of alcohol and heroin in Switzerland. Int J Addict 1992;27:12:1359-1388.
  88. Kolb L. Clinical contribution to drug addiction: The struggle for cure and the conscious reasons for relapse. J Nerv Ment Dis 1927;66:22-43.
  89. Kondo S., Iimuro T., Iwai K. et al. A study of recovery factor about drug addiction recovery center DARC. Nihon Arukoru Yakubutsu Igakkai Zasshi 2000;35:4:258-270.
  90. Kornor H., Waal H. From opioid maintenance to abstinence: a literature review. Drug Alcohol Rev 2005;24:3:267-274.
  91. Kosten T.R., Kleber H.D. Strategies to improve compliance with narcotic antagonists. Am J Drug Alcohol Abuse 1984;10:249-266.
  92. Krupitsky E., Burakov A., Romanova T. et al. Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up. Drug Alcohol Depend 2001;61:3:261-270.
  93. Krupitsky E.M., Zvartau E.E., Masalov D.V. et al. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Substance Abuse Treat 2006;31:4:319-328.
  94. Maddux J.F., Desmond D.B. Relapse and Recovery in Substance Abuse Careers. In: Relapse and Recovery in Drug Abuse. Eds. F.M. Tims, C.G. Leukefeld. NIDA Res Monogr 1986;72:49-72.
  95. Maddux J.F., Desmond D.B. Methadone maintenance and recovery from opioid dependence. Am J Drug Alcohol Abuse 1992;18:1:63-74.
  96. Marsden J., Gossop M., Stewart D. et al. The Maudsley Addiction Profile (MAP): A brief instrument for assessing treatment outcome. Addiction 1998;93:12:1857-1867.
  97. Mattick R.P., Breen C., Kimber J., Davoli M. Methadon maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003;2:CD002209.
  98. McCance-Katz E.F., Kosten T.R. Psychopharmacological treatments. In: Clinical textbook of addictive disorders. Eds. R. Frances, S. Miller. 2nd. ed. New York: The Gilford Press 1998;596-625.
  99. McLellan A.T., Luborsky L., Woody G.E., O’Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980;168:1:26-33.
  100. McLellan A.T., Luborsky L., Woody G.E. et al. Are the «addiction-related» problems of substance abusers really related? J Nerv Ment Dis 1981;169:4:232-239.
  101. Mezinskis J.P., Honos-Webb L., Kropp F., Somoza E. The measurement of craving. J Addict Dis 2001;20:3:67-85.
  102. Mufti K.A., Said S., Farooq S. et al. Five year follow up of 100 heroin addicts in Peshawar. J Ayub Med Coll Abbottabad 2004;16:3:5-9.
  103. Mutasa H.C. Risk factors associated with noncompliance with methadone substitution therapy (MST) and relapse amoung chronic opiate users in an Outer London community. J Adv Nurs 2001;35:1:97-107.
  104. Nurco D.N., Kinlock T.W., Hanlon T.E. The nature and status of drug abuse treatment. Md Med J 1994;43:1:51-57.
  105. O’Brien C. Overview: the treatment of drug dependence. Addiction 1994;89:11:1565-1569.
  106. O’Brien C., McLellan A.T. Myths about the treatment of addiction. Lancet 1996;347:8996:237-240.
  107. O`Brien C.P. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiat 2005;162:8:1423-1431.
  108. O’Donnell J.A. Narcotic Addicts in Kentucky. Public Health Service Pub. No. 1881. Washington, D.C.: Supt. of DOCS., U.S. Govt. Print. Off. 1969.
  109. Okruhlica L., Mihalkova A., Klempova D., Skovayova L. Three-year follow up study of heroin users in Bratislava. Eur Addict Res 2002;8:2:103-106.
  110. Ooteman W., Koeter M.W., Vserheul R. et al. Measuring craving: an attempt to connect subjective craving with cue reactivity. Alcohol Clin Exp Res 2006;30:1:57-69.
  111. Oppenheimer E., Sheehan M., Taylor C. What happens to drug misusers? A medium-term follow-up of subjects new to treatment. Br J Addict 1990;85:10:1255-1260.
  112. Parsons J. Opioid dependence. Are pharmacotherapies effective? Austral Family Physician 2002;31:1:4-5.
  113. Pauchard D., Calanca D. Catamnestic study of 76 cases of heroin addiction among young adults. Schwiez Arch Neurol Neurochir Psychiat 1983;133:2:321-345.
  114. Powell J., Dawe S., Richards D. et al. Can opiate tell us about their relapce risk? Subjective predictors of clinical prognosis. Addict Behav 1993;18:4:473-490.
  115. Preston K.L., Silverman K., Umbricht A. et al. Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend 1999;54:127-135.
  116. Price R.K., Risk N.K., Spritznagel E.L. Remission from drug abuse over a 25-year period: patterns of remission and treatment use. Am J Public Health 2001;91:7:1107-1113.
  117. Rao S.R., Broome K.M., Simpson D.D. Depression and hostility as predictors of long-term outcomes among opiate users. Addiction 2004;99:5:579-589.
  118. Rathod N.H., Addenbrooke W.M., Rosenbach A.F. Heroin dependence in an English town: 33-year follow-up. Br J Psychiat 2005;187:421-425.
  119. Rea F., Bell J.R., Young M.R., Mattick R.P. A randomized, controlled trial of low dose naltrexone for the treatment of opioid dependence. Drug Alcohol Depend 2004;75:1:79-88.
  120. Ritsher J.B., Moos R.H., Finney J.W. Relationship of treatment orientation and continued care to remission among substance abuse patients. Psychiat Service 2002;53:5:595-601.
  121. Robins L.N., Helzer J.E., Hesselbrock M., Wish E. Vietnam veterans three years after Vietnam: How our study changed our view of heroin. In: The Yearbook of Substance Use and Abuse. Eds. L. Brill, C. Winick. Vol. 2. New York: Human Sciences Press 1980;213-230.
  122. Rosengren D.B., Downey L., Donovan D.M. «I already stopped»: Abstinence prior to treatment. Addiction 2000;95:1:65-76.
  123. Rounsaville B.J., Kosten T.R., Kleber H.D. The antecendents and benefits of achieving abstinence in opioid addicts: a 2,5 year follow-up study. Am J Drug Alcohol Abuse 1987;13:3:213-229.
  124. Sanchez-Carbonel J., Brigos B., Cami J. Outcome of a sample of heroin addicts 2 year after the beginning of treatment. Med Clin 1989;92:4:135-139.
  125. Scharse R. Cessation patterns among neophyte heroin users. Int J Addict 1966;1:23-32.
  126. See R.E. Neural substrates of conditioned-cued relapse to drug-seeking behavior. Pharmacol Biochem Behav 2002,71:3:517-529.
  127. Sheehan M., Oppenheimer E., Taylor C. Opiate users and the first years after treatment outcome analysis of the proportion of follow up time spent in abstinence. Addiction 1993;88:12:1679-1689.
  128. Shewan D., Dalgrano P. Evidence of controlled heroin use? Low levels of negative health and social outcomes among non-treatment heroin users in Glasgow (Scotland). Br J Health Psychol 2005;10:Pt 1:33-48.
  129. Silverman K., Svikis D., Wong C.J. et al. A Reinforcement-based therapeutic workplace for the treatment of drug abuse: Three-year abstinence outcomes. Exp Clin Psychopharmacol 2002;10:3:228-240.
  130. Simpson D., Sells S. Effectiveness of treatment for drug abuse: an overview of the DARP research program. Adv Alcohol Subst Abuse 1982;2:7-29.
  131. Simpson D.D., Marsh K.L. Relapse and recovery among opioid addicts 12 years after treatment. In: Relapse and Recovery in Drug Abuse. Eds. F.M. Tims, C.G. Leukefeld. NIDA Res Monogr 1986;72:86-103.
  132. Simpson D.D., Joe G.W., Brown B.S. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997;11:4:294-307.
  133. Sinha R., Kimmerling A., Doebrick C., Kosten T.R. Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology (Berl) 2007;190:4:569-574.
  134. Smith B.R., Barry J., Lane A. et al. In-patient treatment of opiate dependence: medium-term follow-up outcomes. Br J Psychiat 2005;187:360-365.
  135. Smith J.W., Frawley P.J. Treatment outcome of 600 chemically dependent treated in a multimodal inpatient program including aversion therapy and pentothal interviews. J Subst Abuse Treat 1993;10:4:359-369.
  136. Smyth B., Hoffman V., Fan, J., Hser Y.-I. Years of potential life lost among heroin addicts 33 years after treatment. Prevent Med 2007;44:4:369-374.
  137. Stella L., D’Ambra C., Mazzeo F. et al. Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients. Life Sci 2005;77:21:2717-2722.
  138. Stinchfield R., Owen P. Hazelden’s model of treatment and its outcome. Addict Behav 1998;23:5:669-683.
  139. Strang J.,   McCambridge J., Best D. et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. Br Med J 2003;326:959-960.
  140. Treatment protocol effectiveness study. By Barry R McCaffry; United States. Office of National Drug Control Policy. Treatment Outcome Working Group. Washington, D.C.: The Office 1996.
  141. Vaillant G.E. A 20-year old follow-up of New York narcotic addicts. Arch Gen Psychiat 1973;29:237-241.
  142. Waldorf D., Biernacki P. Natural recovery from heroin addiction: A review of the incidence literature. J Drug Iss 1979;9:281-289.
  143. Waldorf D. Natural recovery from opiate addiction: Some social-psychological processes of untreated recovery. J Drug Iss 1983;13:237-280.
  144. Winick C. Maturing out of narcotic addiction. Bull Narcol 1962;14:1-7.
  145. Winick C. The life cycle of the narcotic addict and of addiction. Bull Narcol 1964;16:1-11.
  146. Woody G.E., Luborsky L., McLellan A.T. et al. Psychotherapy for opiate addicts. Arch Gen Psychiat 1983;40:6:639-645.
  147. Woody G.E., McLellan A.T., Luborsky L., O’Brien C.P. Twelve-month follow-up of psychotherapy for opiate dependence. Am J Psychiat 1989;144:5:590-596.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.